Mar 16, 2022 / 02:40PM GMT
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good morning. Welcome to Day 2 of Oppenheimer's Annual Healthcare Conference. My name is Michael Wiederhorn. I'm the health care services analyst. Today, we are hosting Amedisys. We have Chris Gerard, COO and incoming CEO; Scott Ginn, Chief Financial Officer; and Nick Muscato, Senior VP of Finance. We'll be doing the fire side. We also, for the audience, there should be a Q&A portal in the top right corner of your screen that you can submit questions into. Feel free to use that at any time.
So welcome. Thanks, guys, for joining me virtually here. Hopefully, next year, we'll be back in person.
Questions and Answers:
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior AnalystBut I'll start right here with kind of a high-level question. If you kind of just give me an update or just discuss what you're seeing in terms of trends post the Omicron peak? Kind of give us an update there, start with that.